The study revealed a significant (p < 0.005) increase in adiponectin concentration in the blood of children with juvenile idiopathic arthritis who had not undergone etanercept therapy compared to healthy children. This evidence concerns the gene ADIPOQ and juvenile idiopathic arthritis.